Objectively Monitoring Amyotrophic Lateral Sclerosis Patient Symptoms During Clinical Trials With Sensors:

Luis Garcia-Gancedo1, Madeline L Kelly2, Arseniy Lavrov3

  • 1Advanced Biostatistics & Data Analytics Centre of Excellence, R&D Projects Clinical Platforms & Sciences, GlaxoSmithKline, Stevenage, United Kingdom.

JMIR Mhealth and Uhealth
|December 21, 2019
PubMed
Summary

Remote monitoring using a digital platform showed feasibility for collecting physical activity, heart rate variability, and speech data in Amyotrophic Lateral Sclerosis (ALS) patients. While speech data was successful, physical activity data quantity was lower than anticipated, though still useful for novel endpoints.

Related Concept Videos